Research output per year
Research output per year
Personal profile
Headline
PROFESSOR Medicine, Hematology and Medical Oncology PROFESSOR Pediatrics
Biography
My clinical practice focuses exclusively on patients (both adult and pediatric) who undergo BMT and overlaps with my clinical research. I have designed, conducted, analyzed, and authored multiple clinical trials and data analyses of clinical GVHD, specifically, and clinical BMT, broadly. My long term goal is to improve outcomes for patients who undergo BMT by designing and conducting high impact clinical trials. I co-direct the Mount Sinai Acute GVHD International Consortium [MAGIC] with Dr. James Ferrara. This international consortium provides the opportunity to develop and test innovative treatment approaches for allogeneic BMT patients.
Fingerprint
Dive into the research topics where John Levine is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
18 F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation
Holter-Chakrabarty, J., McNally, L., Levine, J., Ferrara, J., Vesely, S. K., Kanakry, C. G., Garwe, T., Han, Z., Pandey, M., Glover, J., Wen, Y., Gress, R. & Williams, K. M., 2025, In: Radiology: Imaging Cancer. 7, 1, e240096.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Correction to: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002 (Bone Marrow Transplantation, (2023), 58, 12, (1416-1418), 10.1038/s41409-023-02110-4)
Meyers, G., Hamadani, M., Martens, M., Ali, H., Chevallier, P., Choe, H., Harris, A. C., Holler, E., van Hooren, E., Klaassen, W., Leifer, E., van Oosterhout, Y., Perez, L., Pusic, I., Stelljes, M., van der Velden, W., Ammatuna, E., Beauvais, D., Cornillon, J. & Maziarz, R. T. & 5 others, , 2025, (Accepted/In press) In: Bone Marrow Transplantation.Research output: Contribution to journal › Comment/debate
-
Donor telomeres and their magnitude of shortening post-allogeneic haematopoietic cell transplant impact survival for patients with early-stage leukaemia or myelodysplastic syndrome
Gadalla, S. M., Katki, H. A., Lai, T. P., Auer, P. L., Dagnall, C. L., Bupp, C., Hutchinson, A. A., Anderson, J. J., Mendez, K. J. W., Spellman, S. R., Stewart, V., Savage, S. A., Lee, S. J., Levine, J. E., Saber, W. & Aviv, A., Apr 2025, In: eBioMedicine. 114, 105641.Research output: Contribution to journal › Article › peer-review
Open Access -
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease
Walters, M. C., Eapen, M., Liu, Y., Rassi, F. E., Waller, E. K., Levine, J. E., Strouse, J. J., Antin, J. H., Parikh, S. H., Bakshi, N., Dampier, C., Jaroscak, J. J., Bergmann, S., Wong, T., Kota, V., Pace, B., Lekakis, L. J., Lulla, P., Nickel, R. S. & Kasow, K. A. & 12 others, , 11 Mar 2025, In: Blood advances. 9, 5, p. 955-965 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Prediction and Prognostication of Acute Graft-Versus-Host Disease by MAGIC Biomarkers
Levine, J. E., May 2025, In: American Journal of Hematology. 100, S3, p. 5-13 9 p.Research output: Contribution to journal › Review article › peer-review
Press/Media
-
Studies from Icahn School of Medicine at Mount Sinai Add New Findings in the Area of Biomarkers (Serial Clinical and Biomarker Monitoring During Graft-versus-host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-low Risk ...)
Levine, J., Etra, A. & Akahoshi, Y.
24/02/25
1 item of Media coverage
Press/Media
-
Nikolaos Katsivelos, MD, and John Levine, MD, MS, on How Serial Clinical and Biomarker Monitoring During Treatment Can Stratify Patients With Low-Risk GVHD
2/01/25
1 item of Media coverage
Press/Media
-
Rachel E. Rau, MD, and Sumit Gupta, MD, PhD, on Pediatric B-Cell ALL: Blinatumomab Added to Chemotherapy in Newly Diagnosed Disease
10/12/24
1 item of Media coverage
Press/Media
-
Nitin Jain, MD, on First-Line Treatment With Pirtobrutinib-Based Regimen in CLL
10/12/24
1 item of Media coverage
Press/Media